Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Borosilicate bioactive glasses with added Mg/Sr enhances human adipose-derived stem cells osteogenic commitment and angiogenic properties.

Tainio JM., Vanhatupa S., Miettinen S., Massera J.

Laboratory Study on Face & Skin, published in J Mater Sci Mater Med (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Mater Sci Mater Med (2024)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
39614975
PMCID
PMC11608307
DOI
10.1007/s10856-024-06830-x
Citations
2

Abstract (original English)

Bioactive glasses are one of the most promising materials for applications in bone tissue engineering. In this study, the focus was on borosilicate bioactive glasses with composition 47.12 SiO 2 - 6.73 B 2 O 3 - 21.77-x-y CaO - 22.65 Na 2 O - 1.72 P 2 O 5 - x MgO - y SrO (mol%). These compositions are based on silicate S53P4 bioactive glass, from where 12.5% of SiO 2 is replaced with B 2 O 3 , and additionally, part of CaO is substituted for MgO and/or SrO. The impact of ion release, both as extract and in direct contact, on human adipose-derived stem cells' (hADSCs) viability, proliferation, ECM maturation, osteogenic commitment and endothelial marker expression was assessed. Osteogenic media supplements were utilized with the extracts, and in part of the direct cell/material culturing conditions. While it has been reported in other studies that boron release can induce cytotoxicity, the glasses in this study supported cells viability and proliferation. Moreover, borosilicate's, especially with further Mg/Sr substitutions, upregulated several osteogenic markers (such as RUNX2a, OSTERIX, DLX5, OSTEOPONTIN), as well as angiogenic factors (e.g., vWF and PECAM-1). Furthermore, the studied glasses supported collagen-I production even in the absence of osteogenic supplements, when hADSCs were cultured in contact with the glasses, suggesting that while the bioactive glass degradation

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansOsteogenesisGlassCell ProliferationSilicatesCell DifferentiationAdipose TissueCell SurvivalStem CellsTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research